UBS Group AG - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 204 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 16.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$844,929
-1.0%
18,372
+23.7%
0.00%
Q2 2023$853,315
-1.0%
14,848
-35.4%
0.00%
Q1 2023$862,126
+80.2%
22,990
+34.6%
0.00%
Q4 2022$478,414
+10.2%
17,074
+10.5%
0.00%
Q3 2022$434,000
-54.7%
15,450
-43.9%
0.00%
Q2 2022$958,000
-4.4%
27,536
-1.3%
0.00%
Q1 2022$1,002,000
+220.1%
27,889
+107.8%
0.00%
Q4 2021$313,000
+77.8%
13,418
+44.9%
0.00%
Q3 2021$176,000
-71.7%
9,260
-70.0%
0.00%
Q2 2021$623,000
-19.0%
30,887
-26.4%
0.00%
Q1 2021$769,000
-11.1%
41,943
-2.4%
0.00%
Q4 2020$865,000
+170.3%
42,981
+152.1%
0.00%
Q3 2020$320,000
-59.9%
17,051
-52.0%
0.00%
Q2 2020$798,000
+74.2%
35,542
+15.1%
0.00%
Q1 2020$458,000
-63.7%
30,879
-52.8%
0.00%
Q4 2019$1,262,000
+0.3%
65,464
+3.1%
0.00%
Q3 2019$1,258,000
+12.8%
63,468
+20.1%
0.00%
Q2 2019$1,115,000
+27.7%
52,836
+23.7%
0.00%
Q1 2019$873,000
+214.0%
42,726
+205.3%
0.00%
Q4 2018$278,000
-3.8%
13,996
-6.9%
0.00%
Q3 2018$289,000
+489.8%
15,033
+364.7%
0.00%
Q2 2018$49,000
-62.6%
3,235
-53.4%
0.00%
Q1 2018$131,000
+3.1%
6,947
+5.3%
0.00%
Q4 2017$127,000
+54.9%
6,595
+44.5%
0.00%
Q3 2017$82,000
-38.8%
4,565
-39.4%
0.00%
Q2 2017$134,000
-1.5%
7,529
-19.5%
0.00%
Q1 2017$136,000
-21.8%
9,349
-1.3%
0.00%
Q4 2016$174,000
-33.1%
9,474
-30.8%
0.00%
Q3 2016$260,000
+134.2%
13,700
+98.6%
0.00%
Q2 2016$111,000
-52.6%
6,900
-64.6%
0.00%
Q1 2016$234,000
-19.9%
19,500
-5.2%
0.00%
Q4 2015$292,000
+1068.0%
20,574
+859.2%
0.00%
Q3 2015$25,000
+177.8%
2,145
+329.0%
0.00%
Q2 2015$9,000
-85.9%
500
-88.3%
0.00%
Q1 2015$64,000
+2033.3%
4,273
+1765.9%
0.00%
Q4 2014$3,0002290.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders